Translating a complex formulation into a final sterile dosage form requires uncompromising process engineering and absolute control over the manufacturing environment. In the advanced biopharmaceutical landscape, mitigating physical and chemical risks during fill-finish operations is paramount to preserving the integrity of high-value active pharmaceutical ingredients (APIs). BOC Sciences provides highly specialized sterile drug product manufacturing services designed to transition your fluid formulations into robust, market-ready products. Utilizing advanced isolation technology, customized fluid path engineering, and automated processing, we deliver exceptional precision across liquid vial filling, lyophilization, and pre-filled syringe (PFS) operations. Our engineering teams focus relentlessly on yield maximization, shear stress reduction, and maintaining absolute sterility, ensuring your most fragile therapeutic molecules are processed flawlessly.
In the pre-production phase, we focus on efficiently translating laboratory results into industrial-scale production while ensuring product quality and consistency.
We provide a wide range of flexible filling solutions for the final presentation of sterile drug products across multiple dosage formats.
For drugs unstable in liquid form, such as proteins and vaccines, we offer comprehensive freeze-drying solutions to preserve molecular activity.
We provide professionally customized sterile solutions for complex or high-risk therapeutic modalities requiring advanced handling.
Partner with our technical experts to bridge the gap between formulation development and industrial-scale aseptic manufacturing with absolute consistency.
BOC Sciences engineered platforms are adaptable to a vast array of fluid dynamics and chemical stabilities, ensuring structural integrity across diverse molecular formats.
Facing bottlenecks in sterile filling or capacity constraints? Our aseptic manufacturing suites and automated fill-finish lines are designed to ensure precision, scalability, and consistent batch performance for your sterile drug products.
Upon receiving your inquiry, our team reviews your product profile, formulation, and production needs to assess feasibility and outline an appropriate sterile manufacturing approach.
We align key process parameters with your formulation data and define a manufacturing plan to ensure efficient integration into our sterile production platform.
Our team conducts compounding, sterile filtration, and aseptic filling in controlled environments to ensure consistent process performance and product integrity.
After production, we finalize batch documentation and coordinate product delivery according to the agreed project timeline.
Transitioning laboratory or pilot-scale processes to commercial volumes often introduces shifts in mixing efficiency, shear forces, and filling parameters, which can jeopardize product stability and lead to batch-to-batch variability. We leverage extensive experience in tech transfer to optimize critical process parameters (CPPs), ensuring a controlled scale-up that maintains consistent and reproducible product quality at high-volume production.
Different container closure systems—such as vials, pre-filled syringes, or cartridges—demand specific equipment configurations, often leading to capacity constraints or compatibility issues. Our versatile, automated filling lines support multiple dosage formats and batch sizes. Through flexible production scheduling and precise sterile operations, we eliminate bottlenecks and ensure your project stays on the agreed timeline.
Sterile drug products are highly susceptible to degradation, precipitation, or loss of activity during filtration and filling. We provide comprehensive process adaptation and optimization services, including formulation assessment, sterile filtration validation, and aseptic process mapping. This rigorous approach minimizes stability risks and ensures that your most sensitive molecules remain reliable throughout the entire manufacturing cycle.
Improperly designed freeze-drying cycles can result in cake collapse, loss of biological activity, and extended development timelines. Our engineering team utilizes advanced lyophilization equipment to develop highly efficient and controllable cycles. By seamlessly integrating these cycles with our aseptic filling workflows, we safeguard the long-term stability, batch uniformity, and final quality of your injectable products.
Partner with BOC Sciences to leverage advanced isolator technologies, dedicated single-use flow paths, and elite process engineering. From viscous biologics to delicate lyophilized powders, we ensure flawless execution for your most critical manufacturing campaigns.
We do not rely on "one-size-fits-all" templates. Every fluid pathway, pump speed, and thermal cycle is mathematically tailored to the specific physical properties of your molecule.
Our integration of 100% in-line check weighing, advanced visual inspection, and automated container closure testing ensures that deviations are caught and corrected instantly.
With rapid changeover Single-Use Systems (SUS), our facility infrastructure can seamlessly pivot between distinct batch sizes and varying container formats without scheduling delays.
Our process engineers excel at resolving complex tech transfer hurdles, whether addressing unforeseen formulation foaming, filtration pressure spikes, or difficult reconstitution profiles.
Client Needs: A biopharmaceutical partner required the full-scale aseptic manufacturing of a high-value recombinant protein, necessitating a production partner capable of eliminating API waste during the fill-finish stage.
Challenges: Previous attempts elsewhere resulted in significant product loss (12%) within the sterile filtration housing before filling could be completed.
Manufacturing Strategy: Our production team implemented a custom-engineered, closed-loop Single-Use System (SUS) architecture specifically designed to minimize dead volume. By reducing the internal diameter of the transfer tubing and utilizing a specialized micro-filtration capsule, we significantly lowered the surface-area-to-volume ratio. Furthermore, we integrated an advanced, automated gas-purge sequence at the conclusion of the batch. This system uses sterile-grade inert gas to physically recovery the remaining formulated bulk from the filtration assembly and filling needles, ensuring every milligram of the high-value API is transitioned into the final vials without introducing turbulence or air bubbles.
Outcome: We successfully manufactured the batch with a final yield of 99.1%. This efficient production allowed the client to maximize their market-ready supply while significantly reducing material costs.
Client Needs: A company required the commercial-scale sterile manufacturing of a monoclonal antibody delivered in a lyophilized format.
Challenges: The product faced severe instability issues, including cake collapse, when attempting to move from benchtop samples to industrial-scale production lots.
Manufacturing Strategy: Utilizing our large-scale automated production lyophilizers, our engineers employed Process Analytical Technology (PAT) to map the exact sublimation kinetics of the formulation. We calculated the precise variance in heat transfer coefficients between the development-scale shelf and the production-scale environment. Based on these thermal models, we adjusted the primary drying ramp rates and implemented dynamic chamber pressure controls to maintain a stable sublimation front. Multiple engineering runs were executed to synchronize the thermal profile across the entire shelf area, ensuring that the moisture removal process was uniform for every vial in the batch.
Outcome: We delivered uniform, high-quality lyophilized drug products with rapid reconstitution times (under 60 seconds). The final product demonstrated perfect stability, meeting all technical specifications.
Client Needs: A developer needed a reliable sterile manufacturing partner for a novel, fragile large-molecule peptide highly susceptible to mechanical degradation.
Challenges: Standard high-velocity filling equipment caused protein unfolding and particulate generation, which compromised the physical integrity and performance of the final syringes.
Manufacturing Strategy: To protect the fragile molecular structure, we completely bypassed standard peristaltic and rotary piston pumps in favor of specialized low-shear diaphragm pumping systems. Our engineering team redesigned the internal geometry of the filling nozzles to maximize the cross-sectional area, thereby lowering the dispense velocity at the point of exit. We further synchronized the filling stroke with the needle movement to maintain a strict laminar flow regime as the fluid entered the syringe barrel. This comprehensive approach minimized fluid-to-surface friction and mechanical impact, preventing the aggregation typically caused by high-velocity splashing and turbulent flow.
Outcome: Our manufacturing process eliminated shear-induced aggregation. Automated inspection confirmed zero sub-visible particles, preserving the biological efficacy and physical stability of the fragile peptide.
Commercial drug manufacturing enables large-scale, efficient production to meet growing market demand. Optimized processes and precise controls reduce costs and improve batch consistency. BOC Sciences provides customized solutions, combining advanced equipment and expert teams to support the entire workflow from process development to mass production, ensuring efficiency and stable product quality.
Key factors include process development capability, production scale, technical equipment, and project management experience. An experienced supplier can optimize workflows according to client needs. BOC Sciences offers flexible production solutions, technical guidance, and full communication support to help clients efficiently scale up drug manufacturing.
Consistency in commercial drug production is achieved through standardized processes, strict monitoring, and quality management systems. Controlling critical parameters, raw material quality, and workflow minimizes variability. BOC Sciences has extensive experience in process optimization and scale-up, providing reproducible and stable production processes that meet high standards for drug consistency and control.
Cost control relies on optimized raw material sourcing, improved process efficiency, and proper equipment allocation. Batch production and workflow optimization can reduce unit costs while maintaining quality. BOC Sciences offers production optimization advice and develops cost-effective plans, helping companies achieve cost control and maximize return on investment.
Large-scale production requires mature process scale-up capabilities, equipment adaptability, and project management expertise. Systematic processes and batch operations enable high capacity and stable output. BOC Sciences provides end-to-end support from process optimization to scaled production, leveraging expert teams and advanced facilities to deliver scalable, reliable manufacturing solutions.
When handling our high-potency API, every milliliter matters. The engineering team at BOC Sciences optimized our fluid pathway so effectively that our line losses were virtually non-existent. Their attention to mechanical detail directly impacted our bottom line.
— Marcus T., VP of CMC & Manufacturing, Oncology Biotech
We struggled with cake collapse during our own pilot runs. BOC Sciences' thermal engineers mapped the thermodynamics brilliantly, tweaking the chamber pressure and ramp rates to deliver a perfect, robust cycle at production scale.
— Elena G., Director of Formulation Engineering, Biopharma Inc.
The level of automation in their isolator lines is impressive. From the 100% inline weight checks to the robotic handling, the reduction in human intervention gave us tremendous confidence in the physical integrity of our sterile product.
— David L., Head of Supply Chain, Therapeutics Developer
Tech transfer is usually a nightmare of delays and miscommunications. BOC Sciences mapped our process parameters efficiently, flagged potential filtration issues immediately, and executed the engineering runs precisely on schedule. Highly reliable partners.
— Sarah K., Principal Process Engineer, Global Pharma
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
